Since the Ki67 antibody has been used to assess cardiomyocyte nuclear proliferative activity in mitogenic cardiomyopathy, it was used to assess the nuclear activity in the Sphynx cats with the ALMS1 variants and hypertrophic cardiomyopathy reported here [15]. Here, ALMS1 is linked to hypertrophic cardiomyopathy.